If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEurocell Regulatory News (ECEL)

Share Price Information for Eurocell (ECEL)

Share Price is delayed by 15 minutes
Get Live Data
112.00    -2.00 (-1.75%)
Bid:
112.00
Ask:
114.00
Spread: 2.00 (1.786%)
Market Cap: £110.38m
ECEL Live PriceLast checked at - London Stock Exchange

Intraday Eurocell Share Chart

Director/PDMR Shareholding

11 Apr 2017 15:58

RNS Number : 2378C
Eurocell plc
11 April 2017
Β 

11 April 2017

Β 

Eurocell plc

Β 

Director/PDMR Shareholding

Β 

Eurocell plc (the "Company") announces that on 7 April 2017 awards were granted under the Eurocell plc Save as You Earn Scheme to two directors.

Β 

The notifications set out below, made in accordance with the requirements of the EU Market Abuse Regulation, provide further detail.

Β 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

Β 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Mark Kelly

2.

Reason for the notification

a)

Position / status

Chief Executive Officer

b)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Eurocell plc

b)

Legal Entity Identifier

N/A

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary shares of Β£0.001 each in the Company ("Ordinary Shares")

ISIN Number GB00BVV2KN49

b)

Nature of the transaction

Grant of an option to acquire shares under the Company Save as You Earn Scheme

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Β£1.632

11,029

d)

Aggregated information

- Aggregated volume

- Aggregated price

- Aggregated total

Β 

Β 

N/A - single transaction

e)

Date of the transaction

7 April 2017

f)

Place of the transaction

Outside a trading venue

Β 

Β 

Β 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Michael Scott

2.

Reason for the notification

a)

Position / status

Chief Financial Officer

b)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Eurocell plc

b)

Legal Entity Identifier

N/A

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary shares of Β£0.001 each in the Company ("Ordinary Shares")

ISIN Number GB00BVV2KN49

b)

Nature of the transaction

Grant of an option to acquire shares under the Company Save as You Earn Scheme

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Β£1.632

11,029

d)

Aggregated information

- Aggregated volume

- Aggregated price

- Aggregated total

Β 

Β 

N/A - single transaction

e)

Date of the transaction

7 April 2017

f)

Place of the transaction

Outside a trading venue

Β 

Β 

For further information:

Eurocell plc 01773 842 100

Gerald Copley

Company Secretary

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
DSHGGUQACUPMGCG
Date   Source Headline
20th Feb 20247:00 amRNSTransaction in Own Shares
19th Feb 20247:00 amRNSTransaction in Own Shares
16th Feb 20247:00 amRNSTransaction in Own Shares
15th Feb 20246:00 pmRNSHolding(s) in Company
15th Feb 20247:00 amRNSTransaction in Own Shares
14th Feb 20247:00 amRNSTransaction in Own Shares
13th Feb 20247:00 amRNSDirector/PDMR Shareholding
13th Feb 20247:00 amRNSTransaction in Own Shares
8th Feb 20247:00 amRNSTransaction in Own Shares
7th Feb 20247:00 amRNSTransaction in Own Shares
6th Feb 20247:00 amRNSTransaction in Own Shares
5th Feb 20247:00 amRNSTransaction in Own Shares
2nd Feb 20247:00 amRNSTransaction in Own Shares
1st Feb 20247:00 amRNSTransaction in Own Shares
1st Feb 20247:00 amRNSNon-executive Directors' Share Purchase Plan
30th Jan 20247:04 amRNSTransaction in Own Shares
29th Jan 20247:00 amRNSTransaction in Own Shares
26th Jan 20247:00 amRNSTransaction in Own Shares
25th Jan 20247:00 amRNSDirectorate Change
25th Jan 20247:00 amRNSTransaction in Own Shares
24th Jan 20247:00 amRNSTransaction in Own Shares
23rd Jan 20247:00 amRNSYear End Trading Update
23rd Jan 20247:00 amRNSLaunch of Share Buyback Programme
27th Dec 20237:00 amRNSHolding(s) in Company
19th Dec 20234:30 pmRNSHolding(s) in Company
29th Nov 20234:30 pmRNSDirector/PDMR Shareholding
14th Nov 20234:30 pmRNSDirector/PDMR Shareholding
3rd Nov 20234:30 pmRNSHolding(s) in Company
2nd Nov 20237:00 amRNSDirector/PDMR Shareholding
16th Oct 20234:30 pmRNSHolding(s) in Company
16th Oct 20234:30 pmRNSDirector/PDMR Shareholding
13th Oct 20234:30 pmRNSHolding(s) in Company
22nd Sep 20237:00 amRNSInvestor Presentation
21st Sep 20234:30 pmRNSDirector/PDMR Shareholding
7th Sep 20236:30 pmRNSDirector/PDMR Shareholding
5th Sep 20237:00 amRNSHalf-year Results
4th Sep 20237:00 amRNSBlock listing Interim Review
9th Aug 20234:30 pmRNSDirector/PDMR Shareholding
25th Jul 20237:00 amRNSTrading Update - In Line with Expectations
17th Jul 20237:00 amRNSHolding(s) in Company
18th May 20237:00 amRNSHolding(s) in Company
16th May 20234:00 pmRNSHolding(s) in Company
16th May 20237:00 amRNSHolding(s) in Company
15th May 20235:00 pmRNSChanges to Board Committee Memberships
12th May 20237:00 amRNSTrading Update and Board Changes
11th May 20234:30 pmRNSResult of AGM
10th May 20237:00 amRNSDirector/PDMR Shareholding
24th Apr 20237:00 amRNSDirector/PDMR Shareholding
17th Apr 20237:00 amRNSDirector/PDMR Shareholding
13th Apr 20237:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.